Jun 11, 2014
Biodel to Present at the JMP Securities Healthcare Conference
Biodel Inc. management will be presenting an overview of the Company's technologies, development programs, and outlook at the JMP Securities Healthcare Conference being held at The Westin New York Grand Central from June 24-25, 2014.
Biodel to Present Data on Ultra-Rapid-Acting Insulin and Glucagon...
Updated safety and efficacy data from Phase II trial of ultra-rapid-acting recombinant human insulin formulation BIOD-123 in patients with Type 1 Diabetes presented in Oral Scientific Session.
Biodel's (BIOD) CEO Dr. Errol De Souza on Q2 2014 Results - Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to Biodel's Second Quarter Fiscal Year 2014 Financial Results Conference Call.
Biodel Inc. To Report Second Quarter Fiscal Year 2014 Financial Results On May 13, 2014
Biodel Inc. will issue its second quarter fiscal year 2014 financial results on May 13, 2014.
Biodel Inc. Announces Collaboration Agreement With for Development of ...
Biodel Inc. today announced the signing of a research supply and technology development agreement with the HEC Pharm subsidiary Yichang Chang Jiang Pharmaceutical Co., Ltd for ultra-rapid-acting insulin aspart.